Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Oakmark Select Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+8%
YTD+24.77%
Annualized+11.35%
Positioning StanceConstructive
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Outperforming the S&P 500. The concentrated fund added IQVIA at attractive valuations while maintaining its disciplined value approach."
Executive Summary
The Oakmark Select Fund returned 0.08% in Q3 2023 and 30.59% for the fiscal year, outperforming the S&P 500's 21.62% fiscal year return despite significant headwinds to value investing. Growth stocks outperformed value by 2,300 basis points year-to-date, creating a challenging environment for the fund's value-oriented approach. Key contributors included Charter Communications, Alphabet, First Citizens, and Oracle, while detractors were IQVIA Holdings, Capital One Financial, and Meta Platforms. The fund initiated a new position in IQVIA, a leading clinical trials and healthcare technology provider, purchasing shares at approximately 15x normal earnings despite the company's above-average growth prospects. IQVIA benefits from strong data and digital capabilities that enable market share gains as pharma companies outsource to contract research organizations. The managers maintain confidence that their disciplined stock selection approach will generate attractive long-term returns. The fund anticipates paying no capital gains distribution this year for tax efficiency.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
72%
CautiousHigh
High Conviction (72%)
The fund demonstrates high conviction through its concentrated portfolio structure and detailed analysis of new position IQVIA, including specific valuation metrics (15x normal earnings) and comprehensive thesis. However, the absence of specific position sizing for most holdings and hedged language about long-term expectations prevents a higher score.
Growth Outlook
25%
BearishBullish
Bearish (25%)
The managers acknowledge significant headwinds to value investing with growth outperforming value by 2,300 basis points, but express confidence in their long-term approach and ability to find attractive opportunities like IQVIA at trough multiples.
Risk Appetite
40%
DefensiveAggressive
Defensive (40%)
The fund initiated a new position in IQVIA during a sector decline and maintained all existing positions, showing selective risk-taking. However, they acknowledge the challenging environment for value investing and focus on disciplined selection.
Capital Deployment
25%
De-riskingDeploying
De-risking (25%)
The fund initiated one new position (IQVIA) during the quarter and eliminated no positions, suggesting modest net deployment. However, without specific cash level changes or sizing details, the deployment appears selective rather than aggressive.
Forward Guidance
30%
CautiousExpansionary
Cautious (30%)
Management expects their disciplined approach will drive attractive returns in the long term, showing confidence in their strategy despite current headwinds. They are selectively adding positions like IQVIA when opportunities arise.
Language Signal
20%
BearishBullish
Bearish (20%)
Language is balanced with positive terms like 'pleased,' 'attractive returns,' and 'strong track record' offset by acknowledgment of 'headwinds,' 'detractors,' and challenging value environment.
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
The managers acknowledge meaningful risks including significant value underperformance (2,300 basis points) and sector-specific challenges in healthcare. However, these are presented as temporary headwinds rather than systemic threats, with confidence expressed in long-term strategy.
Opportunity Density
60%
ScarceAbundant
Selective (60%)
The managers found an attractive opportunity in IQVIA at trough valuations despite challenging conditions, suggesting selective opportunities exist. Their confidence in long-term stock selection implies a reasonable opportunity set, though current value headwinds limit immediate prospects.
Time Horizon
75%
Short-TermLong-Term
Decade+ (75%)
The fund emphasizes long-term returns and expects their disciplined approach to drive attractive returns 'in the long term.' The detailed analysis of IQVIA's sustainable growth prospects and focus on fundamental value over short-term performance indicates a multi-year investment horizon.